Shapiro R L, Kumar L, Phillips-Howard P, Wells J G, Adcock P, Brooks J, Ackers M L, Ochieng J B, Mintz E, Wahlquist S, Waiyaki P, Slutsker L
Foodborne and Diarrheal Diseases Branch, National Center for Infectious Diseases and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
J Infect Dis. 2001 Jun 1;183(11):1701-4. doi: 10.1086/320710. Epub 2001 Apr 25.
Bacterial diarrheal diseases cause substantial morbidity and mortality in sub-Saharan Africa, but data on the epidemiology and antimicrobial susceptibility patterns of enteric bacterial pathogens are limited. Between May 1997 and April 1998, a clinic-based surveillance for diarrheal disease was conducted in Asembo, a rural area in western Kenya. In total, 729 diarrheal specimens were collected, and 244 (33%) yielded >or=1 bacterial pathogen, as determined by standard culture techniques; 107 (44%) Shigella isolates, 73 (30%) Campylobacter isolates, 45 (18%) Vibrio cholerae O1 isolates, and 33 (14%) Salmonella isolates were identified. Shigella dysenteriae type 1 accounted for 22 (21%) of the Shigella isolates. Among 112 patients empirically treated with an antimicrobial agent and whose stool specimens yielded isolates on which resistance testing was done, 57 (51%) had isolates that were not susceptible to their antimicrobial treatment. Empiric treatment strategies for diarrheal disease in western Kenya need to be reevaluated, to improve clinical care.
细菌性腹泻疾病在撒哈拉以南非洲地区导致了大量发病和死亡,但关于肠道细菌病原体的流行病学和抗菌药物敏感性模式的数据有限。1997年5月至1998年4月期间,在肯尼亚西部的一个农村地区阿森博开展了一项基于诊所的腹泻病监测。总共收集了729份腹泻标本,按照标准培养技术测定,其中244份(33%)培养出≥1种细菌病原体;鉴定出107份(44%)志贺菌分离株、73份(30%)弯曲杆菌分离株、45份(18%)霍乱弧菌O1分离株和33份(14%)沙门菌分离株。1型痢疾志贺菌占志贺菌分离株的22份(21%)。在112例接受了抗菌药物经验性治疗且粪便标本培养出分离株并进行了耐药性检测的患者中,57例(51%)的分离株对其接受的抗菌治疗不敏感。肯尼亚西部腹泻病的经验性治疗策略需要重新评估,以改善临床护理。